Oculosympathetic palsy, more commonly referred to as Horner's syndrome, is a neurological condition in dogs that arises from disruption of the sympathetic nerve supply to the eye and surrounding structures. The sympathetic pathway responsible for normal ocular function extends from the hypothalamus in the brain through the spinal cord, exits at the thoracic region, travels along the cervical vagosympathetic trunk, and ultimately reaches the eye via the middle ear region. Damage or interruption at any point along this three-neuron pathway produces the characteristic clinical signs associated with this condition.
The hallmark presentation of oculosympathetic palsy includes a classic triad of signs: miosis (constriction of the pupil), ptosis (drooping of the upper eyelid), and enophthalmos (recession of the eyeball into the orbit). A fourth sign, protrusion of the third eyelid (nictitating membrane), is particularly prominent in dogs and often serves as one of the most noticeable indicators to pet owners. These signs are almost always unilateral, affecting only one side of the face.
While the appearance of Horner's syndrome can be alarming to dog owners, the condition itself is generally not painful and does not directly impair vision. However, the syndrome is important because it frequently signals an underlying disease process that may be more serious. Identifying the root cause of the sympathetic nerve disruption is the primary clinical challenge and the focus of the diagnostic workup.
Oculosympathetic palsy can occur in dogs of any age, breed, or sex, though certain breeds may be more frequently affected. The prognosis for recovery depends entirely on the underlying cause. Idiopathic cases, in which no identifiable cause is found, represent a substantial proportion of diagnoses in dogs and generally carry a favorable prognosis with spontaneous resolution over weeks to months.
Veterinarians classify the location of the lesion along the sympathetic pathway as first-order (central), second-order (preganglionic), or third-order (postganglionic) based on pharmacological testing. This localization is critical because it narrows the list of potential underlying causes and guides the diagnostic approach. Understanding where the nerve disruption occurs helps determine whether the problem originates in the brain, spinal cord, chest, neck, or middle ear region.
